Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study

NCT00421863 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1111

Enrollment

OTHER

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Triatec 10 mg
DRUG: Triatec HCT 5
DRUG: Lasix 25
DRUG: Micardis 80 mg
DRUG: Micardis plus 80/12.5
DRUG: Catapresan TTS 2
DRUG: Norvasc 10 mg
DRUG: Triatec 5 mg
DRUG: Pluscor

Sponsor

Heart Care Foundation